Educational Videos

Expand your knowledge about CAR T-cell therapies and autoimmune diseases from scientist and patient perspectives.

Spotlight on Autoimmunity: KYSA-8 Phase 2 Trial in Refractory Stiff Person Syndrome

Learn more about a Phase 2 Trial using an anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in patients with Stiff Person Syndrome (SPS) who fail standard therapies. CAR T-cell therapy uses the patient's own immune cells to treat disease.